• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Docetaxel, cisplatin, and fluorouracil in gastric cancer: does the punishment fit the crime?

作者信息

Ilson David H

出版信息

J Clin Oncol. 2007 Aug 1;25(22):3188-90. doi: 10.1200/JCO.2006.10.2210.

DOI:10.1200/JCO.2006.10.2210
PMID:17664464
Abstract
摘要

相似文献

1
Docetaxel, cisplatin, and fluorouracil in gastric cancer: does the punishment fit the crime?多西他赛、顺铂和氟尿嘧啶用于治疗胃癌：这样的治疗是否恰当？
J Clin Oncol. 2007 Aug 1;25(22):3188-90. doi: 10.1200/JCO.2006.10.2210.
2
Clinical benefit with docetaxel plus fluorouracil and cisplatin compared with cisplatin and fluorouracil in a phase III trial of advanced gastric or gastroesophageal cancer adenocarcinoma: the V-325 Study Group.多西他赛联合氟尿嘧啶和顺铂与顺铂和氟尿嘧啶在晚期胃癌或胃食管腺癌III期试验中的临床获益比较：V-325研究组
J Clin Oncol. 2007 Aug 1;25(22):3205-9. doi: 10.1200/JCO.2006.10.4968.
3
Quality of life with docetaxel plus cisplatin and fluorouracil compared with cisplatin and fluorouracil from a phase III trial for advanced gastric or gastroesophageal adenocarcinoma: the V-325 Study Group.多西他赛联合顺铂和氟尿嘧啶与顺铂和氟尿嘧啶用于晚期胃或胃食管腺癌的III期试验中的生活质量比较：V - 325研究组
J Clin Oncol. 2007 Aug 1;25(22):3210-6. doi: 10.1200/JCO.2006.08.3956.
4
[Docetaxel-Cisplatin-5-Fu Combination Chemotherapy as a First-line Treatment in Patients with Metastatic or Recurred Gastric Cancer].
Korean J Gastroenterol. 2007 Sep;50(3):207-209.
5
Phase II multi-institutional randomized trial of docetaxel plus cisplatin with or without fluorouracil in patients with untreated, advanced gastric, or gastroesophageal adenocarcinoma.多西他赛联合顺铂加或不加氟尿嘧啶用于未经治疗的晚期胃癌或胃食管腺癌患者的多机构II期随机试验。
J Clin Oncol. 2005 Aug 20;23(24):5660-7. doi: 10.1200/JCO.2005.17.376.
6
Phase II study of sequential cisplatin plus 5-fluorouracil/leucovorin (5-FU/LV) followed by irinotecan plus 5-FU/LV followed by docetaxel plus 5-FU/LV in patients with metastatic gastric or gastro-oesophageal junction adenocarcinoma.顺铂联合氟尿嘧啶/亚叶酸（5-FU/LV）序贯治疗后伊立替康联合 5-FU/LV 及多西紫杉醇联合 5-FU/LV 治疗转移性胃或胃食管结合部腺癌的Ⅱ期临床研究。
Cancer Chemother Pharmacol. 2010 Aug;66(3):559-66. doi: 10.1007/s00280-009-1196-1. Epub 2010 Mar 17.
7
Epirubicin, Cisplatin, and protracted venous-infusion Fluorouracil in advanced esophagogastric cancer.
J Clin Oncol. 2002 Oct 1;20(19):4124-5; author reply 4125-6. doi: 10.1200/JCO.2002.99.125.
8
Chemotherapy for advanced gastric or gastroesophageal cancer: defining the contributions of docetaxel.晚期胃癌或胃食管癌的化疗：确定多西他赛的作用
Expert Opin Pharmacother. 2006 Aug;7(12):1627-31. doi: 10.1517/14656566.7.12.1627.
9
[Clinical development of chemotherapy for advanced gastric cancer].[晚期胃癌化疗的临床进展]
Nihon Shokakibyo Gakkai Zasshi. 2007 Feb;104(2):186-93.
10
Docetaxel in gastric cancer: a viewpoint by David Wilson.
Drugs. 2007;67(13):1902-3. doi: 10.2165/00003495-200767130-00009.

引用本文的文献

1
Integrated analysis of single-cell and bulk RNA-sequencing data reveals the prognostic value and molecular function of THSD7A in gastric cancer.单细胞和批量 RNA 测序数据的综合分析揭示了 THSD7A 在胃癌中的预后价值和分子功能。
Aging (Albany NY). 2023 Oct 30;15(21):11940-11969. doi: 10.18632/aging.205158.
2
Multicenter Phase II Study of Cabazitaxel in Advanced Gastroesophageal Cancer: Association of HER2 Expression and M2-Like Tumor-Associated Macrophages with Patient Outcome.多中心 II 期研究卡巴他赛在晚期胃食管交界处癌中的应用：HER2 表达与 M2 样肿瘤相关巨噬细胞与患者预后的相关性。
Clin Cancer Res. 2020 Sep 15;26(18):4756-4766. doi: 10.1158/1078-0432.CCR-19-3920. Epub 2020 Jul 8.
3
Chemotherapy for advanced gastric cancer.
晚期胃癌的化疗
Cochrane Database Syst Rev. 2017 Aug 29;8(8):CD004064. doi: 10.1002/14651858.CD004064.pub4.
4
Methylation-mediated gene silencing as biomarkers of gastric cancer: a review.甲基化介导的基因沉默作为胃癌生物标志物的综述
World J Gastroenterol. 2014 Sep 14;20(34):11991-2006. doi: 10.3748/wjg.v20.i34.11991.
5
High pathologic complete remission rate from induction docetaxel, platinum and fluorouracil (DCF) combination chemotherapy for locally advanced esophageal and junctional cancer.多西他赛、铂类和氟尿嘧啶（DCF）联合诱导化疗用于局部晚期食管癌和食管交界癌时的高病理完全缓解率。
Med Oncol. 2014 Sep;31(9):188. doi: 10.1007/s12032-014-0188-0. Epub 2014 Aug 23.
6
Phase I/II trial of 2-weekly docetaxel combined with cisplatin plus fluorouracil in metastatic esophageal cancer (JCOG0807).多西他赛每两周一次联合顺铂及氟尿嘧啶用于转移性食管癌的I/II期试验（JCOG0807）
Cancer Sci. 2014 Sep;105(9):1189-95. doi: 10.1111/cas.12486.
7
HDM2 regulation by AURKA promotes cell survival in gastric cancer.AURKA 调控 HDM2 促进胃癌细胞存活。
Clin Cancer Res. 2014 Jan 1;20(1):76-86. doi: 10.1158/1078-0432.CCR-13-1187. Epub 2013 Nov 15.
8
Metachronous rectum metastases from gastric adenocarcinoma: a case report.胃腺癌异时性直肠转移：一例报告
Case Rep Med. 2012;2012:726841. doi: 10.1155/2012/726841. Epub 2012 Nov 25.
9
Randomised phase II trial of docetaxel and sunitinib in patients with metastatic gastric cancer who were previously treated with fluoropyrimidine and platinum.多西他赛和舒尼替尼治疗既往氟嘧啶和铂类治疗的转移性胃癌患者的随机 II 期试验。
Br J Cancer. 2012 Apr 24;106(9):1469-74. doi: 10.1038/bjc.2012.100. Epub 2012 Mar 29.
10
Phase II study of modified docetaxel, cisplatin, and fluorouracil with bevacizumab in patients with metastatic gastroesophageal adenocarcinoma.贝伐珠单抗联合改良多西紫杉醇、顺铂和氟尿嘧啶治疗转移性胃食管腺癌的 II 期临床研究。
J Clin Oncol. 2011 Mar 1;29(7):868-74. doi: 10.1200/JCO.2010.32.0770. Epub 2010 Dec 28.